Inquirer on MSN1h
US approves first-ever obstructive sleep apnea drug
On December 20, 2024, pharmaceutical company Eli Lilly announced that the FDA approved its first and only obstructive sleep ...
7 times the Apple Watch predicted danger and saved a life in 2024
Wearables continued to rise in popularity this year, with Apple's devices proving to be lifesaving in these harrowing true ...
8 times the Apple Watch predicted danger and saved lives in 2024
Wearables continued to rise in popularity this year, with Apple's devices proving to be lifesaving in these harrowing true stories.
Bradford Era1d
BRMC’s Sleep Disorders Center achieves milestone in patient care
The sleep disorders center at Bradford Regional Medical Center (BRMC), a Kaleida Health facility, achieved a milestone in ...
FDA approves Zepbound for sleep apnea in obese adults
Zepbound, a drug approved by the FDA, has been shown to reduce the severity of obstructive sleep apnea in obese adults, ...
Everyday Health4d
FDA Approves First Medication for Obstructive Sleep Apnea
By aiding weight loss, Zepbound can improve symptoms of obstructive sleep apnea (OSA) in people with obesity — but CPAP ...
Hosted on MSN4d
FDA Approves Zepbound in Landmark Move to Battle Obstructive Sleep Apnea
The fight against obstructive sleep apnea (OSA) has taken a monumental leap forward. For the first time, the U.S. Food and ...
McKnight's Long-Term Care News4d
FDA approves Zepbound for sleep apnea in patients with obesity
The US Food and Drug Administration has approved Zepbound (tirzepatide) as the first prescription medication for the treatment of obstructive sleep apnea (OSA).
Sleep apnea gets its first drug: Why US FDA approves weight loss drug for use
The United States Food and Drug Administration (FDA) has approved the weight-loss drug Tirzepatide — sold by the brand name ...